Marci Laudenslager1, Zoobia W Chaudhry2, Selvi Rajagopal2, Sasha Clynes3, Kimberly A Gudzune2,3. 1. The Johns Hopkins University School of Medicine, Baltimore, MD, USA. mlauden1@jhmi.edu. 2. The Johns Hopkins University School of Medicine, Baltimore, MD, USA. 3. The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Abstract
PURPOSE OF REVIEW: Comprehensive lifestyle programs are cornerstones of obesity management, but clinician referrals may be limited by program availability. Commercial weight loss programs may be an alternative, but clinicians may be unaware of their efficacy and safety. This review describes the evidence for commercial programs, particularly 12-month weight loss, among individuals with obesity. RECENT FINDINGS: Several programs are concordant with evidence-based recommendations (i.e., lower-calorie diet, increased physical activity, and behavioral strategies). Among the guideline-concordant programs, National Diabetes Prevention Program, WW, Jenny Craig, Medifast, and OPTIFAST have demonstrated 12-month weight loss efficacy and safety. While other programs show promise, more evidence is needed before clinician referral may be recommended. Clinical practice guidelines support referrals to commercial weight loss programs that have peer-reviewed evidence to support their efficacy and safety. Clinicians should consider the available evidence, patient preference, and cost when considering referrals to these programs for weight management.
PURPOSE OF REVIEW: Comprehensive lifestyle programs are cornerstones of obesity management, but clinician referrals may be limited by program availability. Commercial weight loss programs may be an alternative, but clinicians may be unaware of their efficacy and safety. This review describes the evidence for commercial programs, particularly 12-month weight loss, among individuals with obesity. RECENT FINDINGS: Several programs are concordant with evidence-based recommendations (i.e., lower-calorie diet, increased physical activity, and behavioral strategies). Among the guideline-concordant programs, National Diabetes Prevention Program, WW, Jenny Craig, Medifast, and OPTIFAST have demonstrated 12-month weight loss efficacy and safety. While other programs show promise, more evidence is needed before clinician referral may be recommended. Clinical practice guidelines support referrals to commercial weight loss programs that have peer-reviewed evidence to support their efficacy and safety. Clinicians should consider the available evidence, patient preference, and cost when considering referrals to these programs for weight management.
Authors: Michael D Jensen; Donna H Ryan; Caroline M Apovian; Jamy D Ard; Anthony G Comuzzie; Karen A Donato; Frank B Hu; Van S Hubbard; John M Jakicic; Robert F Kushner; Catherine M Loria; Barbara E Millen; Cathy A Nonas; F Xavier Pi-Sunyer; June Stevens; Victor J Stevens; Thomas A Wadden; Bruce M Wolfe; Susan Z Yanovski; Harmon S Jordan; Karima A Kendall; Linda J Lux; Roycelynn Mentor-Marcel; Laura C Morgan; Michael G Trisolini; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli Journal: Circulation Date: 2013-11-12 Impact factor: 29.690
Authors: David G Marrero; Kelly N B Palmer; Erin O Phillips; Karen Miller-Kovach; Gary D Foster; Chandan K Saha Journal: Am J Public Health Date: 2016-02-18 Impact factor: 9.308
Authors: William C Knowler; Sarah E Fowler; Richard F Hamman; Costas A Christophi; Heather J Hoffman; Anne T Brenneman; Janet O Brown-Friday; Ronald Goldberg; Elizabeth Venditti; David M Nathan Journal: Lancet Date: 2009-10-29 Impact factor: 79.321
Authors: Ambereen K Mehta; Ruchi S Doshi; Zoobia W Chaudhry; David K Jacobs; Rachit M Vakil; Clare J Lee; Sara N Bleich; Jeanne M Clark; Kimberly A Gudzune Journal: Prev Med Date: 2016-06-30 Impact factor: 4.018
Authors: W Timothy Garvey; Jeffrey I Mechanick; Elise M Brett; Alan J Garber; Daniel L Hurley; Ania M Jastreboff; Karl Nadolsky; Rachel Pessah-Pollack; Raymond Plodkowski Journal: Endocr Pract Date: 2016-05-24 Impact factor: 3.443
Authors: Cynthia M Castro Sweet; Vinay Chiguluri; Rajiv Gumpina; Paul Abbott; Erica N Madero; Mike Payne; Laura Happe; Roger Matanich; Andrew Renda; Todd Prewitt Journal: J Aging Health Date: 2017-01-24
Authors: Jamy D Ard; Kristina H Lewis; Amy Rothberg; Anthony Auriemma; Sally L Coburn; Sarah S Cohen; Judy Loper; Laura Matarese; Walter J Pories; Seletha Periman Journal: Obesity (Silver Spring) Date: 2018-11-13 Impact factor: 5.002
Authors: Deborah F Tate; Lesley D Lutes; Maria Bryant; Kimberly P Truesdale; Karen E Hatley; Zoe Griffiths; Tricia S Tang; Louise D Padgett; Angela M Pinto; June Stevens; Gary D Foster Journal: JAMA Netw Open Date: 2022-08-01